Fidelity Investments’s MBX Biosciences MBX Stock Holding History
Bought
Maintained
Sold
Other funds holding MBX
Fidelity Investments's MBX Position: Q3 2026 in Review
Fidelity Investments increased its MBX Biosciences (MBX) stake by 38% in Q3 2026, buying an estimated $128M and bringing the position to 7,368,420 shares worth $432M. The position accounts for 0.02% of the portfolio, ranked #582.
Fidelity Investments first reported a position in MBX in Q4 2024 and has held it in 8 quarters since. 130 funds tracked by Wall St. Rank hold MBX as of Q3 2026.
- Fidelity Investments held 7,368,420 shares of MBX Biosciences worth $432M as of Q3 2026.
- Fidelity Investments bought 2,045,535 MBX Biosciences shares in Q3 2026, an estimated $128M.
- MBX Biosciences made up 0.02% of Fidelity Investments's portfolio in Q3 2026, its #582 holding.
- Fidelity Investments first reported a position in MBX Biosciences in Q4 2024 and has held it in 8 quarters since.
- 130 funds tracked by Wall St. Rank held MBX Biosciences as of Q3 2026.
Based on Fidelity Investments's 13F filing for Q3 2026, filed 10 Nov 2026.